The U.S. military used an artificial intelligence model developed by American company Anthropic in its strike on Venezuela and abduction of President Nicolas Maduro on January 3, The Wall Street Journal and other U.S. media reported on Friday.
Citing sources of insiders, they reported that Anthropic's AI tool "Claude" was deployed during the raid, which involved airstrikes on multiple sites in the Venezuelan capital. But it remains unclear what specific role the AI model played in the operation, according to the reports.
Anthropic's usage policies explicitly prohibit Claude from being used to facilitate violence, develop weapons, or conduct surveillance. A company spokesperson declined to comment on whether Claude was used in any specific operation, classified or otherwise, stating that any use of the model must comply with the company's usage policies.
The Pentagon declined to comment on the operation.
U.S. military forces carried out a series of bombings in Caracas and other parts of Venezuela in the early hours of Jan. 3, forcibly seizing Maduro and his wife Cilia Flores, before taking them away to the U.S. and putting them into custody in New York.
Venezuela's interior ministry reported that at least 100 people were killed and dozens injured in the U.S. attacks which shocked the international community and raised serious concerns worldwide.
US military used AI model in Venezuela raid
US military used AI model in Venezuela raid
South China's Guangdong Province is accelerating its transformation into an international medical tourism hub, positioning itself as a destination for patients worldwide seeking affordable, high-quality care.
The push follows a joint initiative announced in late March by nine Chinese government departments, including the Ministry of Commerce, aimed at boosting spending by foreign tourists and enhancing exports of tourism services as part of broader efforts to expand the country's service sector.
Every day, some of the most complex surgeries are performed here. Li Zilun, deputy director of the division of vascular surgery at the First Affiliated Hospital of Sun Yat‑sen University, is among the doctors capable of carrying out these intricate procedures.
He recently completed surgery on a patient with an aortic aneurysm, a condition often described as a "time bomb" in the body’s main artery, increasingly common in aging societies around the globe. Li also specializes in highly difficult and pioneering procedures, including repairing leaks caused by failed grafts.
"This was a very challenging case. And then, we implanted the covered stent to eliminate the endoleak. Actually, the outcome was pretty good. The patient will be discharged today," said Li Zilun.
The ability to handle such complex cases -- combining international techniques with domestically produced devices -- is drawing patients from around the world to seek treatment. In addition, high safety standards and low costs are also major draws.
"Our government is encouraging innovation. So, lots of physicians -- including our vascular surgeons -- we are actively involved in the innovation that helps to increase the effectiveness and safety, and also bring down the cost," said Li.
This hospital is one of the first in Guangdong to be designated by the provincial health commission as a pilot site for building an international medical service hub.
The growing number of patients has pushed the hospital to explore new ways to transform every step -- from treatment to payment and everything in between -- into a seamless experience, reducing waiting times and delivering better care for patients.
"I think it's fast. When the patient come here for just about, I think, one week, you can solve the problem," said Xiao Haipeng, president of the First Affiliated Hospital of Sun Yat-sen University.
The hospital is also deepening its international cooperation with top-tier medical institutions, including those at Harvard University.
"Not just for China, for the whole globe, we are facing health care challenges -- emerging infectious disease and chronic, lung infectious diseases, and also the aging population, also the shortage of healthcare workforce," said Xiao.
In response to these challenges, China is promoting its own solutions, including aggressive innovation in artificial intelligence (AI)-driven workflows, while stepping up research and development investment and global engagement along the way.
"In recent years, the innovation in Western medicine is dramatically growing. An example of my hospital -- in the past few years, we have 140 innovations and seven of them are international leading innovations," said Xiao.
As global demand for medical tourism grows, China is positioning itself as a new destination. Official data shows that the number of foreign patients in Guangdong increased by 20 percent last year. Among them, the growth in inpatient admissions was even faster, rising by 76 percent.
Guangdong fast-tracks pilot for int'l medical service hub
